3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
NIH
5
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
19
Lung Neoplasms
18
Breast Neoplasms
12
Multiple Myeloma
10
Carcinoma, Non-Small-Cell Lung
9
Leukemia, Myeloid, Acute
8
Rectal Neoplasms
7
Carcinoma, Hepatocellular
7
Myelodysplastic Syndromes
6
Mouth Neoplasms
6
Sarcoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Pancreatic Neoplasms
5
Oropharyngeal Neoplasms
5
Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Head and Neck Neoplasms
5
Brain Neoplasms
5
Ovarian Neoplasms
4
Melanoma
4
Lymphoma, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Glioma
4
Fallopian Tube Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Lymphoma, T-Cell
3
Lymphoma, Non-Hodgkin
3
Laryngeal Neoplasms
3
Interventions
Vincristine
12
Temozolomide
11
Irinotecan
10
Cyclophosphamide
10
Melphalan
8
Filgrastim
8
Etoposide
7
Ifosfamide
6
Granulocyte Colony-Stimulating Factor
6
Doxorubicin
6
Vinorelbine
5
Gemcitabine
5
Busulfan
5
Thiotepa
4
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Dactinomycin
4
pegfilgrastim
3
liposomal doxorubicin
3
irinotecan sucrosofate
3
fludarabine
3
etoposide phosphate
3
Stem Cell Transplantation
3
Sirolimus
3
Proton Therapy
3
Cisplatin
3
Carboplatin
3
Bone Marrow Transplantation
3
thymoglobulin
2
regorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Rhabdomyosarcoma
×
X-Rays
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled